• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性医药:慢性患者药物治疗优化的新平台。

Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization.

机构信息

Pharmacy Service, University Hospital Virgen del Rocío, Seville, Spain.

Pharmacy Service, University Hospital Virgen de Valme, Seville, Spain.

出版信息

J Med Syst. 2022 Feb 28;46(4):18. doi: 10.1007/s10916-022-01808-0.

DOI:10.1007/s10916-022-01808-0
PMID:35226192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885479/
Abstract

We describe the technological development of a web platform named CHRONIC-PHARMA that integrates three prescription support tools for patients with chronic diseases: Anticholinergic Burden Calculator (ABC), LESS-CHRON criteria and TRIGGER-CHRON. They focus on the optimization and evaluation of pharmacotherapy in patients with chronic diseases, resulting in a useful, single platform that can facilitate the review of pharmacotherapy and improve the safety of chronically ill patients. This is achieved by estimating and reducing the anticholinergic risk (ABC), detecting opportunities for deprescribing drugs and monitoring its success (LESS-CHRON criteria), as well as calculating the risk of adverse drug events (TRIGGER-CHRON). The platform is freely accessible online ( https://chronic-pharma.com/ ) as well as through a mobile application, and therefore easily accessible among the healthcare community.

摘要

我们描述了一个名为 CHRONIC-PHARMA 的网络平台的技术开发,该平台集成了三种针对慢性病患者的处方支持工具:抗胆碱能负担计算器(ABC)、LESS-CHRON 标准和 TRIGGER-CHRON。它们专注于优化和评估慢性病患者的药物治疗,从而形成一个有用的单一平台,方便审查药物治疗并提高慢性病患者的安全性。这是通过估计和降低抗胆碱能风险(ABC)、发现减少药物的机会和监测其成功(LESS-CHRON 标准)以及计算不良药物事件的风险(TRIGGER-CHRON)来实现的。该平台可免费在线访问(https://chronic-pharma.com/),也可通过移动应用程序访问,因此在医疗保健社区中易于访问。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/f0cf7c7a0850/10916_2022_1808_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/fae15e8811ed/10916_2022_1808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/8a02b20efb7f/10916_2022_1808_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/e6705885f727/10916_2022_1808_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/3780c47cc3e8/10916_2022_1808_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/f0cf7c7a0850/10916_2022_1808_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/fae15e8811ed/10916_2022_1808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/8a02b20efb7f/10916_2022_1808_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/e6705885f727/10916_2022_1808_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/3780c47cc3e8/10916_2022_1808_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6f9/8885479/f0cf7c7a0850/10916_2022_1808_Fig5_HTML.jpg

相似文献

1
Chronic-pharma: New Platform for Chronic Patients Pharmacotherapy Optimization.慢性医药:慢性患者药物治疗优化的新平台。
J Med Syst. 2022 Feb 28;46(4):18. doi: 10.1007/s10916-022-01808-0.
2
Feasibility of the Implementation of LESS-CHRON in Clinical Practice: A Pilot Intervention Study in Older Patients With Multimorbidity.LESS-CHRON在临床实践中实施的可行性:一项针对患有多种疾病的老年患者的试点干预研究
Innov Aging. 2023 May 8;7(5):igad042. doi: 10.1093/geroni/igad042. eCollection 2023.
3
Novel tool for deprescribing in chronic patients with multimorbidity: List of Evidence-Based Deprescribing for Chronic Patients criteria.用于多病共存的慢性患者减药的新工具:基于证据的慢性患者减药标准清单。
Geriatr Gerontol Int. 2017 Nov;17(11):2200-2207. doi: 10.1111/ggi.13062. Epub 2017 May 21.
4
Validation of the LESS-CHRON criteria: reliability study of a tool for deprescribing in patients with multimorbidity.LESS-CHRON标准的验证:一种用于多病共存患者减药的工具的可靠性研究
Eur J Hosp Pharm. 2019 Nov;26(6):334-338. doi: 10.1136/ejhpharm-2017-001476. Epub 2018 May 30.
5
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.DEFEAT-多重用药:在老年护理机构中停用抗胆碱能和镇静药物的可行性试验
Int J Clin Pharm. 2019 Feb;41(1):167-178. doi: 10.1007/s11096-019-00784-9. Epub 2019 Jan 18.
6
Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission.入院时患有晚期慢性疾病患者的抗胆碱能负担的流行率、风险因素和不良结局。
Geriatr Gerontol Int. 2018 Aug;18(8):1159-1165. doi: 10.1111/ggi.13330. Epub 2018 Apr 11.
7
Evidence-based strategies for the optimization of pharmacotherapy in older people.老年人药物治疗优化的循证策略。
Drugs Aging. 2012 Jun 1;29(6):477-94. doi: 10.2165/11632400-000000000-00000.
8
Deprescribing of non-antiretroviral therapy in HIV-infected patients.对感染艾滋病毒患者停用非抗逆转录病毒疗法
Eur J Clin Pharmacol. 2020 Mar;76(3):305-318. doi: 10.1007/s00228-019-02785-z. Epub 2019 Dec 21.
9
PREDOSE: a semantic web platform for drug abuse epidemiology using social media.前置:一个利用社交媒体进行药物滥用流行病学研究的语义网平台。
J Biomed Inform. 2013 Dec;46(6):985-97. doi: 10.1016/j.jbi.2013.07.007. Epub 2013 Jul 25.
10
Barriers and facilitators to reducing anticholinergic burden from the perspectives of patients, their carers, and healthcare professionals: A protocol for qualitative evidence synthesis.从患者、患者照顾者和医疗保健专业人员的角度来看减少抗胆碱能负担的障碍和促进因素:定性证据综合的方案。
J Evid Based Med. 2019 Aug;12(3):227-231. doi: 10.1111/jebm.12359.

引用本文的文献

1
Adaptive questionnaires for facilitating patient data entry in clinical decision support systems: methods and application to STOPP/START v2.促进临床决策支持系统中患者数据录入的适应性问卷:方法及在 STOPP/START v2 中的应用
BMC Med Inform Decis Mak. 2024 Nov 5;24(1):326. doi: 10.1186/s12911-024-02742-6.
2
Feasibility of the Implementation of LESS-CHRON in Clinical Practice: A Pilot Intervention Study in Older Patients With Multimorbidity.LESS-CHRON在临床实践中实施的可行性:一项针对患有多种疾病的老年患者的试点干预研究
Innov Aging. 2023 May 8;7(5):igad042. doi: 10.1093/geroni/igad042. eCollection 2023.

本文引用的文献

1
Development, validation and evaluation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)©.制定、验证和评估目标导向的药物审查电子决策支持系统(G-MEDSS)©。
Res Social Adm Pharm. 2022 Jul;18(7):3174-3183. doi: 10.1016/j.sapharm.2021.09.004. Epub 2021 Sep 14.
2
Validating the Chinese geriatric trigger tool and analyzing adverse drug event associated risk factors in elderly Chinese patients: A retrospective review.验证中文老年触发工具并分析老年中国患者药物不良事件相关风险因素:回顾性研究。
PLoS One. 2020 Apr 28;15(4):e0232095. doi: 10.1371/journal.pone.0232095. eCollection 2020.
3
Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative data.
开发一种癌症特异性触发工具,以使用行政数据识别与治疗相关的不良事件。
Cancer Med. 2020 Feb;9(4):1462-1472. doi: 10.1002/cam4.2812. Epub 2020 Jan 3.
4
Position paper on an ageing society.关于老龄化社会的立场文件。
Eur J Hosp Pharm. 2019 Nov;26(6):354-356. doi: 10.1136/ejhpharm-2019-001910. Epub 2019 Jul 24.
5
Validation of the LESS-CHRON criteria: reliability study of a tool for deprescribing in patients with multimorbidity.LESS-CHRON标准的验证:一种用于多病共存患者减药的工具的可靠性研究
Eur J Hosp Pharm. 2019 Nov;26(6):334-338. doi: 10.1136/ejhpharm-2017-001476. Epub 2018 May 30.
6
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.老年人潜在不适当药物/潜在处方遗漏的 STOPP/START 标准:起源和进展。
Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30.
7
Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.抗胆碱能药物处方的特点及老年人高使用率的预测因素:基于人群的研究。
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1591-1600. doi: 10.1002/pds.4902. Epub 2019 Nov 6.
8
Anticholinergic Burden and Dry Mouth in Middle-Aged People.中年人群中的抗胆碱能负担与口干
JDR Clin Trans Res. 2020 Jan;5(1):62-70. doi: 10.1177/2380084419844511. Epub 2019 Apr 23.
9
Adverse Drug Events in Patients with Dementia and Neuropsychiatric/Behavioral, and Psychological Symptoms, a One-Year Prospective Study.痴呆患者药物不良反应与神经精神/行为和心理症状的一年前瞻性研究。
Int J Environ Res Public Health. 2019 Mar 15;16(6):934. doi: 10.3390/ijerph16060934.
10
Validating a Trigger Tool for Detecting Adverse Drug Events in Elderly Patients With Multimorbidity (TRIGGER-CHRON).验证一种用于检测患有多种疾病的老年患者药物不良事件的触发工具(TRIGGER-CHRON)。
J Patient Saf. 2021 Dec 1;17(8):e976-e982. doi: 10.1097/PTS.0000000000000552.